EquityBank Uganda, Microhaem Scientifics Review Progress of IVD Plant Expansion

Equity Bank Uganda’s leadership visited Microhaem Scientifics  to review progress on the company’s expansion of its in-vitro diagnostics (IVD) manufacturing plant.

Microhaem Scientifics, East Africa’s leading medical manufacturing firm, is strategically expanding its in-vitro diagnostics (IVD) manufacturing plant in Ntinda, Kampala with support from Equity Bank Uganda. This expansion aims to boost local production capacity for medical diagnostic kits, including those for HIV, malaria, and sickle cell disease.

The collaboration is part of a broader effort to reduce reliance on imported diagnostic kits and make healthcare more accessible and affordable in Uganda and the region.

Equity Bank Uganda is backing Microhaem’s expansion through financial support, enabling the company to scale up production.

The expansion focuses on increasing the production of various diagnostic test kits, including those for HIV, malaria, and sickle cell disease.

Microhaem Scientifics is the first indigenous IVD manufacturer in the Greater Lakes Region, and this expansion will further enhance local manufacturing capabilities.

The increased local production is expected to reduce reliance on imported diagnostic kits, lower testing costs, and improve access to healthcare services.

The collaboration between Microhaem and Equity Bank is a strategic move to strengthen Uganda’s healthcare infrastructure and ensure the availability of quality diagnostic tools, according to Micro-Haem Scientifics and Medical Supplies Limited.

The expanded facility will also produce kits for HIV Viral Load, HIV EID, Hep B, and HPV.